GSYPX
Price
$41.07
Change
+$0.26 (+0.64%)
Updated
Jul 25 closing price
Net Assets
908.11M
VSIAX
Price
$87.39
Change
+$0.46 (+0.53%)
Updated
Jul 25 closing price
Net Assets
55.61B
Interact to see
Advertisement

GSYPX vs VSIAX

Header iconGSYPX vs VSIAX Comparison
Open Charts GSYPX vs VSIAXBanner chart's image
Goldman Sachs Small Cap Value P
Price$41.07
Change+$0.26 (+0.64%)
VolumeN/A
Net Assets908.11M
Vanguard Small Cap Value Index Admiral
Price$87.39
Change+$0.46 (+0.53%)
VolumeN/A
Net Assets55.61B
GSYPX vs VSIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSYPX vs. VSIAX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSYPX is a Buy and VSIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 55.6B vs. GSYPX (908M). VSIAX pays higher dividends than GSYPX: VSIAX (2.11) vs GSYPX (1.19). GSYPX was incepted earlier than VSIAX: GSYPX (7 years) vs VSIAX (14 years). GSYPX (1.06) is less costly to investors than VSIAX (0.07). GSYPX is a more actively managed with annual turnover of: 83.00 vs. VSIAX (16.00). GSYPX has a lower initial minimum investment than VSIAX: GSYPX (0) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 5.03 vs. GSYPX (-14.24). VSIAX return over 5 years is better than : 88.00 vs. GSYPX (0.36).
GSYPXVSIAXGSYPX / VSIAX
Total Expense Ratio0.950.071,357%
Annual Report Gross Expense Ratio1.060.071,514%
Fund Existence7 years14 years-
Gain YTD1.2662.36254%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets908M55.6B2%
Annual Yield % from dividends1.192.1156%
Returns for 1 year-14.245.03-283%
Returns for 3 years-15.5930.39-51%
Returns for 5 years0.3688.000%
Returns for 10 yearsN/A101.76-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBIO46.300.64
+1.40%
BridgeBio Pharma
VIRT44.200.43
+0.98%
Virtu Financial Inc
NYMTN21.61N/A
N/A
New York Mortgage Trust
ARCT14.94-0.01
-0.07%
Arcturus Therapeutics Holdings
CELU2.96-0.20
-6.33%
Celularity